The outcome of peptide receptor radionuclide therapy (PRRT) in North American patients with advanced well-differentiated neuroendocrine tumors (WD-NETs).
Boris Naraev
No relevant relationships to disclose
Nancy Sharma
No relevant relationships to disclose
Eric Steven Engelman
No relevant relationships to disclose
David L Bushnell
No relevant relationships to disclose
Thomas M. O'Dorisio
No relevant relationships to disclose
Thorvardur Ragnar Halfdanarson
No relevant relationships to disclose